Hisun Biomaterials Overview
- Year Founded
-
2004
- Status
-
Public
- Employees
-
453
- Stock Symbol
-
688203
- Share Price
-
$1.74
- (As of Friday Closing)
Hisun Biomaterials General Information
Description
Zhejiang Hisun Biomaterials Co Ltd is engaged in the research and development, production and sales of polylactic acid.
Contact Information
Website
www.hisunplas.comCorporate Office
- Taizhou Bay Avenue, Taizhou Bay New Area
- Number 188
- Taizhou, Zhejiang 318000
- China
Corporate Office
- Taizhou Bay Avenue, Taizhou Bay New Area
- Number 188
- Taizhou, Zhejiang 318000
- China
Hisun Biomaterials Stock Performance
As of 20-Nov-2026, Hisun Biomaterials’s stock price is $1.74. Its current market cap is $352M with 203M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.74 | $1.87 | $1.24 - $3.93 | $352M | 203M | 13.7M | $0.02 |
Hisun Biomaterials Financials Summary
As of 30-Sep-2026, Hisun Biomaterials has a trailing 12-month revenue of $172M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 560,561 | 340,914 | 225,481 | 289,362 |
| Revenue | 171,721 | 118,434 | 117,789 | 106,478 |
| EBITDA | 6,889 | 12,507 | 15,052 | 13,506 |
| Net Income | 4,702 | 1,372 | 4,948 | 6,155 |
| Total Assets | 311,248 | 292,641 | 282,956 | 289,270 |
| Total Debt | 24,601 | 29,326 | 27,296 | 36,374 |
Hisun Biomaterials Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Hisun Biomaterials Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Hisun Biomaterials Patents
Hisun Biomaterials Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026086307-A1 | Method for analyzing and evaluating degradation resistance of plastics by linear extrapolation on basis of result of high-solids anaerobic digestion test | Pending | 22-Oct-2024 | ||
| WO-2026086309-A1 | Method for analyzing and evaluating plastic degradation resistance on the basis of fitting derivation method for aerobic biodegradation test result under controlled composting condition | Pending | 22-Oct-2024 | ||
| WO-2026086308-A1 | Method for analyzing and evaluating plastic degradation resistance on the basis of fitting derivation method for high-solid anaerobic biodegradation test result | Pending | 22-Oct-2024 | G16C60/00 |
Hisun Biomaterials Signals
Hisun Biomaterials Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Hisun Biomaterials ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Chemicals
Industry
Rank
Percentile
Commodity Chemicals
Subindustry
Rank
Percentile
Hisun Biomaterials FAQs
-
When was Hisun Biomaterials founded?
Hisun Biomaterials was founded in 2004.
-
Where is Hisun Biomaterials headquartered?
Hisun Biomaterials is headquartered in Taizhou, China.
-
What is the size of Hisun Biomaterials?
Hisun Biomaterials has 453 total employees.
-
What industry is Hisun Biomaterials in?
Hisun Biomaterials’s primary industry is Specialty Chemicals.
-
Is Hisun Biomaterials a private or public company?
Hisun Biomaterials is a Public company.
-
What is Hisun Biomaterials’s stock symbol?
The ticker symbol for Hisun Biomaterials is 688203.
-
What is the current stock price of Hisun Biomaterials?
As of 20-Nov-2026 the stock price of Hisun Biomaterials is $1.74.
-
What is the current market cap of Hisun Biomaterials?
The current market capitalization of Hisun Biomaterials is $352M.
-
What is Hisun Biomaterials’s current revenue?
The trailing twelve month revenue for Hisun Biomaterials is $172M.
-
What is Hisun Biomaterials’s annual earnings per share (EPS)?
Hisun Biomaterials’s EPS for 12 months was $0.02.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process